Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome.
Layla MathiesonLilian KoppensteinerDavid A DorwardRichard A O'ConnorAhsan R AkramPublished in: British journal of cancer (2024)
This study describes the fibroblast heterogeneity in NSCLC and the prognostic importance of the novel CAF-S5 subset where its presence correlates to worse survival outcome.